文献速递肝胆胰外科急腹症与外科感染围术期管理与 ERAS

脓毒症合并全身性毛细血管渗漏综合征34例临床分析

[Clinical analysis of 34 cases with sepsis and systemic capillary leak syndrome].
PubMed 文献 · Zhonghua Wai Ke Za Zhi · 2017-01-01

回顾性分析34例脓毒症合并全身性毛细血管渗漏综合征(SCLS)患者的临床数据,比较28天生存组与死亡组在三个时间段的炎症、灌注、液体平衡等指标。生存组在7~9天好转,死亡组持续恶化;7~9天感染未控制且SCLS持续渗漏者预后差、病死率更高。

要点

  • 脓毒症合并SCLS患者1~3天均表现为炎症加重、组织灌注下降、液体正平衡及需NE维持灌注压。
  • 生存组约7~9天进入好转期,炎症减轻、液体转为负平衡、组织水肿改善。
  • 若7~9天感染未控制且SCLS持续渗漏,死亡组脓毒性休克难以纠正并出现多器官衰竭。

核心结论

  • 有效系统治疗7~9天后脓毒症合并SCLS病情可明显好转,应及时给予限制性液体治疗策略。
  • 若第7~9天感染未见好转且SCLS仍处持续渗漏期,患者预后较差、病死率增加。

研究设计与样本

  • 回顾性分析2014年7月至2016年1月解放军总医院肝胆外科ICU收治的34例脓毒症合并SCLS患者临床资料。
  • 男性21例、女性13例,年龄21~74岁,平均56.3岁。
  • 原发病:重症急性胰腺炎18例,肝大部切除术后7例,胰十二指肠术后5例,肝胆管结石行胆道探查T管引流术后4例。
  • 按确诊后28天生存情况分为生存组23例和死亡组11例。
  • 比较两组在1~3天、4~6天、7~9天三个时间段的CRP、PLT、BNP、LAC、OI、NFB及NE使用量,采用t检验和χ2检验。

主要发现

  • 1~3天两组病情均进展:CRP(t=-0.473,P=0.640)和BNP(t=0.140,P=0.895)升高,PLT(t=-0.505,P=0.620)降低,LAC(t=-1.008,P=0.320)和OI(t=-2.379,P=0.020)下降,液体正平衡,均需NE维持灌注压,两组NFB(t=0.910,P=0.370)和NE(t=-0.853,P=0.400)差异无统计学意义。
  • 4~6天生存组达平台期,死亡组恶化:CRP(t=-3.438,P=0.000)、PLT(t=1.649,P=0.110)、BNP(t=-10.612,P=0.000)、LAC(t=-11.305,P=0.000)、OI(t=2.743,P=0.010)、NFB(t=-4.257,P=0.000)和NE(t=-7.956,P=0.000)。
  • 7~9天生存组炎症减轻、CRP及BNP下降、PLT上升、液体转为负平衡、组织水肿改善;死亡组继续恶化并出现多器官衰竭:CRP(t=-10.036,P=0.000)、PLT(t=6.061,P=0.000)、BNP(t=-10.119,P=0.000)、LAC(t=-24.466,P=0.000)、OI(t=13.443,P=0.010)、NFB(t=-8.345,P=0.000)、NE(t=-7.121,P=0.000)。

临床怎么用

  • 对脓毒症合并SCLS患者,应在有效系统治疗基础上于7~9天前后评估感染控制与渗漏状态,及时转为限制性液体治疗。
  • 若7~9天感染未控制且SCLS仍处持续渗漏期,需警惕预后不良并加强器官功能支持。

局限性

  • 单中心回顾性研究,样本量34例,结论需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To study the clinical characteristics of sepsis with systemic capillary leak syndrome(SCLS) and to evaluate the therapeutic effect and clinical significance of fluid therapy adjusted timely in these patients. Methods: The clinical data of 34 patients with sepsis and SCLS in the Department of Hepatobiliary Surgery ICU of General Hospital of People's Liberation Army General Hospital from July 2014 to January 2016 were retrospectively analyzed.There were 21 males and 13 females, aged from 21 to 74 years, with an average age of 56.3 years.Primary disease as follows: 18 cases with severe acute pancreatitis, 7 postoperative cases of subtotal hepatectomy, 5 postoperative cases of pancreatoduodenectomy, 4 postoperative cases of cholelithiasis.These patients were divided into survival group and death group according to their 28-day survival status.The clinical data including C-reactive protein(CRP), platelets (PLT), brain natriuretic peptide (BNP), the level of arterial blood lactic acid(LAC), oxygenation index(PaO2/FiO2, OI), net fluid balance(NFB) and norepinephrine dosage(NE) were collected and compared between two groups at three different intervals(day 1-3, day 4-6, day 7-9). The measurement data and numeration data were statistically analyzed with t test and χ2 test respectively to explore the inherent characteristics of the disease evolution and its clinical significance. Results: The survival group (n=23)and the death group(n=11)had no significant difference in the characteristics of basic clinical characters.The condition of the survival group and the death group were both in progress in 1-3 days period manifested as increased CRP(t=-0.473, P=0.640) and BNP levels(t=0.140, P=0.895), decreased PLT counts(t=-0.505, P=0.620) in the inflammatory response, decreased LAC(t=-1.008, P=0.320) and OI level (t=-2.379, P=0.020)in tissue perfusion index, and positive fluid balance(NFB: t=0.910, P=0.370), required NE(t=-0.853, P=0.400) to maintain effective perfusion pressure with systemic edema in both groups.There was no significant difference of all these clinical parameters between the two groups.The patients' condition of the survival group reached a plateau phase, whereas all relative indicators of the death group implied significant aggravation and deterioration of systemic infection(CRP: t=-3.438, P=0.000; PLT: t=1.649, P=0.110; BNP: t=-10.612, P=0.000), tissue perfusion (LAC: t=-11.305, P=0.000; OI: t=2.743, P=0.010)and tissue edema NFB(t=-4.257, P=0.000) and NE(t=-7.956, P=0.000) in 4-6 days period.In the last 7-9 days period the patients' condition of the survival group took a turn for improvement, yet the condition of the death group continued to deteriorate, refractory septic shock developed and multiple organ dysfunction syndrome followed afterwards inevitably(CRP: t=-10.036, P=0.000; PLT: t=6.061, P=0.000; BNP: t=-10.119, P=0.000; LAC: t=-24.466, P=0.000; OI: t=13.443, P=0.010; NFB: t=-8.345, P=0.000; NE: t=-7.121, P=0.000). Conclusions: The condition of patient with sepsis and SCLS would be improved markedly at the critical turning point around 7-9 days period since the effective systemic treatment began.If the infection does not be significantly constrolled and SCLS still remains in a sustained extravasation period in 7-9 days, the prognosis of these patients may be worse and the mortality may be higher than that of the patients mentioned before. 目的: 探讨脓毒症合并全身性毛细血管渗漏综合征(SCLS)的病程演变特点及适时调整的液体诊疗方案的治疗效果。 方法: 回顾性分析2014年7月至2016年1月解放军总医院肝胆外科重症监护病房收治的34例脓毒症合并SCLS患者的临床资料。男性21例,女性13例;年龄21~74岁,平均56.3岁。原发病:重症急性胰腺炎18例,肝大部切除术后7例,胰十二指肠术后5例,肝胆管结石行胆道探查T管引流术后4例。根据患者确诊后28 d的生存情况分为生存组(n=23)和死亡组(n=11),比较两组患者在不同的治疗时间窗口C反应蛋白(CRP)、血小板计数(PLT)、脑利钠肽(BNP)、动脉血乳酸水平(LAC)、氧合指数(OI)、液体出入量(NFB)及去甲肾上腺素(NE)使用量等指标的变化差异。分别采用t检验和χ2检验分析计量资料和计数资料的差异。 结果: 生存组和死亡组在确诊脓毒症伴SCLS后1~3 d病情呈进展状态,炎症反应逐渐加重,表现为CRP(t=-0.473,P=0.640)和BNP水平(t=0.140,P=0.895)升高,PLT(t=-0.505,P=0.620)降低。组织灌注指标LAC水平(t=-1.008,P=0.320)和OI(t=-2.379,P=0.020)均有不同程度的下降,液体正平衡,均需NE维持有效灌注压,全身水肿明显,两组NFB(t=0.910,P=0.370)和NE(t=-0.853,P=0.400)差异均无统计学意义。第4~6天生存组达平台期,死亡组各指标呈恶化趋势,感染加重(CRP:t=-3.438,P=0.000;PLT:t=1.649,P=0.110;BNP:t=-10.612,P=0.000),组织灌注进一步恶化(LAC:t=-11.305,P=0.000;OI:t=2.743,P=0.010),NFB(t=-4.257,P=0.000)和NE(t=-7.956,P=0.000)呈较高水平。第7~9天生存组炎症反应减轻,CRP及BNP水平明显下降,PLT上升。液体治疗转为负平衡,组织水肿改善,各项指标趋于好转。死亡组继续恶化,脓毒性休克难以纠正,各器官不同程度衰竭(CRP:t=-10.036,P=0.000;PLT:t=6.061,P=0.000;BNP:t=-10.119,P=0.000;LAC:t=-24.466,P=0.000;OI:t=13.443,P=0.010;NFB: t=-8.345,P=0.000;NE:t=-7.121,P=0.000)。 结论: 有效的系统治疗7~9 d后脓毒症伴SCLS病情明显好转,应及时给予限制性液体治疗策略;若第7~9天感染未见好转,则患者预后较差,病死率增加。.

来源:Zhonghua Wai Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Ma HX, Shi XJ, Liang YR, et al. [Clinical analysis of 34 cases with sepsis and systemic capillary leak syndrome]. Zhonghua Wai Ke Za Zhi. 2017. PMID: 28870057. doi:10.3760/cma.j.issn.0529-5815.2017.09.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。